echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Synthetic Routes of 1-CYCLOOCTYLPIPERAZINE

    The Synthetic Routes of 1-CYCLOOCTYLPIPERAZINE

    • Last Update: 2023-05-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    1-Cyclooctylpiperazine is an important compound in the chemical industry, with a wide range of applications in the pharmaceutical, agrochemical, and other industries.
    Synthetic routes for 1-cyclooctylpiperazine can vary depending on the desired purity and yield of the final product, as well as the availability and cost of starting materials.


    One common synthetic route for 1-cyclooctylpiperazine involves the reaction of cyclooctanone with piperazine in the presence of a strong acid catalyst, such as sulfuric or phosphoric acid.
    This route involves the formation of a Michael addition product between the cyclooctanone and piperazine, followed by dehydration to produce the desired 1-cyclooctylpiperazine.


    An alternative synthetic route for 1-cyclooctylpiperazine involves the reaction of an alkylating agent, such as methyl iodide or ethyl bromide, with cyclooctene in the presence of a Lewis acid catalyst, such as aluminum chloride or ferric chloride.
    This route involves the formation of a Grignard reagent or organobromide, which can then be treated with piperazine to form the desired 1-cyclooctylpiperazine.


    Another synthetic route for 1-cyclooctylpiperazine involves the reaction of cyclooctene with an amine, such as piperazine or N,N-dimethylamine, in the presence of an acid catalyst, such as hydrochloric acid.
    This route involves the formation of an imine intermediate, which can then be reduced to form the desired 1-cyclooctylpiperazine.


    The choice of synthetic route for 1-cyclooctylpiperazine depends on a variety of factors, including the cost and availability of starting materials, the desired purity and yield of the product, and the reaction conditions necessary to achieve these objectives.
    These factors must be carefully considered in order to optimize the synthesis of 1-cyclooctylpiperazine and ensure that the resulting product meets the necessary specifications for use in the desired applications.


    In the pharmaceutical industry, 1-cyclooctylpiperazine is used as an intermediate in the synthesis of certain drugs, such as antihistamines and antipsychotics.
    In the agrochemical industry, 1-cyclooctylpiperazine is used as a herbicide or insecticide.
    In both industries, the purity and yield of 1-cyclooctylpiperazine are critical factors in ensuring the effectiveness and safety of the final product.


    Overall, the synthetic routes for 1-cyclooctylpiperazine are numerous and varied, and the choice of route depends on a variety of factors.
    The optimal synthetic route must be carefully considered in order to produce a high-quality product that meets the necessary specifications for use in the desired applications.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.